Cargando…
Retraction Note: MiR-140 targets RAP2A to enable the proliferation of insulin-treated ovarian granulosa cells
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936696/ https://www.ncbi.nlm.nih.gov/pubmed/36797762 http://dx.doi.org/10.1186/s13048-023-01118-0 |
_version_ | 1784890282976739328 |
---|---|
author | Xiong, Zhengfang Li, Bing Wang, Wenjuan Zeng, Xianghui Li, Binye Jian, Shengyan Wang, Liyun |
author_facet | Xiong, Zhengfang Li, Bing Wang, Wenjuan Zeng, Xianghui Li, Binye Jian, Shengyan Wang, Liyun |
author_sort | Xiong, Zhengfang |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9936696 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-99366962023-02-18 Retraction Note: MiR-140 targets RAP2A to enable the proliferation of insulin-treated ovarian granulosa cells Xiong, Zhengfang Li, Bing Wang, Wenjuan Zeng, Xianghui Li, Binye Jian, Shengyan Wang, Liyun J Ovarian Res Retraction Note BioMed Central 2023-02-16 /pmc/articles/PMC9936696/ /pubmed/36797762 http://dx.doi.org/10.1186/s13048-023-01118-0 Text en © BioMed Central 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Retraction Note Xiong, Zhengfang Li, Bing Wang, Wenjuan Zeng, Xianghui Li, Binye Jian, Shengyan Wang, Liyun Retraction Note: MiR-140 targets RAP2A to enable the proliferation of insulin-treated ovarian granulosa cells |
title | Retraction Note: MiR-140 targets RAP2A to enable the proliferation of insulin-treated ovarian granulosa cells |
title_full | Retraction Note: MiR-140 targets RAP2A to enable the proliferation of insulin-treated ovarian granulosa cells |
title_fullStr | Retraction Note: MiR-140 targets RAP2A to enable the proliferation of insulin-treated ovarian granulosa cells |
title_full_unstemmed | Retraction Note: MiR-140 targets RAP2A to enable the proliferation of insulin-treated ovarian granulosa cells |
title_short | Retraction Note: MiR-140 targets RAP2A to enable the proliferation of insulin-treated ovarian granulosa cells |
title_sort | retraction note: mir-140 targets rap2a to enable the proliferation of insulin-treated ovarian granulosa cells |
topic | Retraction Note |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936696/ https://www.ncbi.nlm.nih.gov/pubmed/36797762 http://dx.doi.org/10.1186/s13048-023-01118-0 |
work_keys_str_mv | AT xiongzhengfang retractionnotemir140targetsrap2atoenabletheproliferationofinsulintreatedovariangranulosacells AT libing retractionnotemir140targetsrap2atoenabletheproliferationofinsulintreatedovariangranulosacells AT wangwenjuan retractionnotemir140targetsrap2atoenabletheproliferationofinsulintreatedovariangranulosacells AT zengxianghui retractionnotemir140targetsrap2atoenabletheproliferationofinsulintreatedovariangranulosacells AT libinye retractionnotemir140targetsrap2atoenabletheproliferationofinsulintreatedovariangranulosacells AT jianshengyan retractionnotemir140targetsrap2atoenabletheproliferationofinsulintreatedovariangranulosacells AT wangliyun retractionnotemir140targetsrap2atoenabletheproliferationofinsulintreatedovariangranulosacells |